| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |